158 related articles for article (PubMed ID: 12389291)
1. Bone morphogenetic proteins: relevance in spine surgery.
Khan SN; Sandhu HS; Lane JM; Cammisa FP; Girardi FP
Orthop Clin North Am; 2002 Apr; 33(2):447-63, ix. PubMed ID: 12389291
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins for spinal fusion.
Carlisle E; Fischgrund JS
Spine J; 2005; 5(6 Suppl):240S-249S. PubMed ID: 16291119
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
Boden SD
Spine (Phila Pa 1976); 2001 Apr; 26(8):850. PubMed ID: 11317102
[No Abstract] [Full Text] [Related]
4. Evidence supporting the use of bone morphogenetic proteins for spinal fusion surgery.
Robinson Y; Heyde CE; Tschöke SK; Mont MA; Seyler TM; Ulrich SD
Expert Rev Med Devices; 2008 Jan; 5(1):75-84. PubMed ID: 18095899
[TBL] [Abstract][Full Text] [Related]
5. Safety profile for the clinical use of bone morphogenetic proteins in the spine.
Poynton AR; Lane JM
Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S40-8. PubMed ID: 12205419
[TBL] [Abstract][Full Text] [Related]
6. Biology of lumbar spine fusion and use of bone graft substitutes: present, future, and next generation.
Boden SD
Tissue Eng; 2000 Aug; 6(4):383-99. PubMed ID: 10992434
[TBL] [Abstract][Full Text] [Related]
7. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
[TBL] [Abstract][Full Text] [Related]
8. Experimental spinal fusion with recombinant human bone morphogenetic protein-2.
Schimandle JH; Boden SD; Hutton WC
Spine (Phila Pa 1976); 1995 Jun; 20(12):1326-37. PubMed ID: 7676329
[TBL] [Abstract][Full Text] [Related]
9. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
10. Video-assisted lateral intertransverse process arthrodesis. Validation of a new minimally invasive lumbar spinal fusion technique in the rabbit and nonhuman primate (rhesus) models.
Boden SD; Moskovitz PA; Morone MA; Toribitake Y
Spine (Phila Pa 1976); 1996 Nov; 21(22):2689-97. PubMed ID: 8961457
[TBL] [Abstract][Full Text] [Related]
11. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
[TBL] [Abstract][Full Text] [Related]
12. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes as an adjunct for lumbar fusion.
Kaiser MG; Groff MW; Watters WC; Ghogawala Z; Mummaneni PV; Dailey AT; Choudhri TF; Eck JC; Sharan A; Wang JC; Dhall SS; Resnick DK
J Neurosurg Spine; 2014 Jul; 21(1):106-32. PubMed ID: 24980593
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
[TBL] [Abstract][Full Text] [Related]
14. Reversing the inhibitory effect of nicotine on spinal fusion using an osteoinductive protein extract.
Silcox DH; Boden SD; Schimandle JH; Johnson P; Whitesides TE; Hutton WC
Spine (Phila Pa 1976); 1998 Feb; 23(3):291-6; discussion 297. PubMed ID: 9507615
[TBL] [Abstract][Full Text] [Related]
15. Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.
Hofstetter CP; Hofer AS; Levi AD
J Neurosurg Spine; 2016 Mar; 24(3):457-75. PubMed ID: 26613283
[TBL] [Abstract][Full Text] [Related]
16. Development of a New Zealand white rabbit model of spinal pseudarthrosis repair and evaluation of the potential role of OP-1 to overcome pseudarthrosis.
Grauer JN; Vaccaro AR; Kato M; Kwon BK; Beiner JM; Patel TC; Hilibrand AS; Chiba K; Albert TJ
Spine (Phila Pa 1976); 2004 Jul; 29(13):1405-12. PubMed ID: 15223930
[TBL] [Abstract][Full Text] [Related]
17. Current use of biologic graft extenders for spinal fusion.
Coseo NM; Saldua N; Harrop J
J Neurosurg Sci; 2012 Sep; 56(3):203-7. PubMed ID: 22854588
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion.
Martin GJ; Boden SD; Titus L
Spine (Phila Pa 1976); 1999 Nov; 24(21):2188-93; discussion 2193-4. PubMed ID: 10562982
[TBL] [Abstract][Full Text] [Related]
19. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2.
Itoh H; Ebara S; Kamimura M; Tateiwa Y; Kinoshita T; Yuzawa Y; Takaoka K
Spine (Phila Pa 1976); 1999 Jul; 24(14):1402-5. PubMed ID: 10423783
[TBL] [Abstract][Full Text] [Related]
20. Application of bone morphogenetic proteins in spinal fusion.
Gupta MC; Khan SN
Cytokine Growth Factor Rev; 2005 Jun; 16(3):347-55. PubMed ID: 15878841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
